| Title | Erythema multiforme after use of topical dorzolamide. | | Author(s) | Munshi V, Ahluwalia H | | Institution | Birmingham and Midland Eye Centre, Birmingham, United Kingdom., Eye Department, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, United Kingdom. | | Source | J Ocul Pharmacol Ther 2008 Feb; 24(1):91-3. | | Abstract | Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 18370879 |
|
